The $5.6 million Series A funding round for HD, a healthcare and surgery marketplace with headquarters in Thailand, has been completed.
According to a statement released by HD on Wednesday, SBI Ven Capital, a division of the well-known Japanese Internet-based financial behemoth SBI Group, spearheaded this major round through its joint fund with South Korea’s Kyobo Securities and NTU Singapore’s NTUitive.
Along with the addition of new investor TA Ventures, previous backers M Venture Partners, FEBE Ventures, Partech Partners, Ratio Ventures, and Orvel Ventures also participated in the round.
A portion of the new investment, according to the statement, will be used to improve HD’s care delivery systems.
Following the signing of a strategic partnership with Johnson & Johnson MedTech in July of last year, the company has continued to place a strong emphasis on improving patient outcomes and care delivery.
With this most recent funding, HD is also well-positioned to grow. By2025, the company hopes to support 300 operating rooms and more than 5,000 healthcare providers, allowing for thousands more surgeries.
Thus far, the company has helped more than 300,000 patients receive inexpensive, easily accessible medical care and surgeries.
“In emerging Southeast Asian markets, the real opportunity for healthcare artificial intelligence (AI) lies not in building yet another general practitioner chatbot, but in enhancing patient outcomes by streamlining operational and administrative tasks for providers and payers,
“Our unique MEhdIQ LLM, with its exclusive and anonymized training data, aims to significantly alleviate the administrative load, allowing healthcare and insurance professionals to focus on delivering superior patient care,” said Sheji Ho, Chief Executive Officer and Co-Founder of HD.
As per the statement, HD has grown three times since the last funding round in December 2022, and this funding milestone is evidence of that.
Since its launch in late 2022, HD’s flagship product, the HDcare platform, has grown 160 times.
HDcare is a leader in elective surgery solutions, filling a significant need in the area by seamlessly connecting patients with high-quality, reasonably priced surgical care.
A Lancet study that shows that 52% of higher-income Asia-Pacific countries have adequate access to surgery, compared to 91% of Southeast Asians who do not. This disparity is quite noticeable.
